Unique ID issued by UMIN | UMIN000005916 |
---|---|
Receipt number | R000006996 |
Scientific Title | Investigation on the effect of sodium intake and anti-hypertensive therapy in the treatment Hypertension |
Date of disclosure of the study information | 2011/07/04 |
Last modified on | 2012/10/11 17:09:35 |
Investigation on the effect of sodium intake and anti-hypertensive therapy in the treatment Hypertension
Valsartan-Tochigi Hypertension study UNDER monitoring of salt intake(Val-THUNDER)
Investigation on the effect of sodium intake and anti-hypertensive therapy in the treatment Hypertension
Valsartan-Tochigi Hypertension study UNDER monitoring of salt intake(Val-THUNDER)
Japan |
Hypertension
Medicine in general | Gastroenterology | Cardiology |
Endocrinology and Metabolism |
Others
NO
Evaluate an additional hypotensive effect and safety profile of either ARB/CCB or ARB/Diuretics combination in the uncontrolled hypertensive patients treated with normal dose of ARB.
The study is also going to evaluate if the therapy could better respond to the Patients with low or high sodium intake to suggest better application of combined drug to the specific patient type.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
1)Office BP
2)Change before and after treatment of the following items:Cr,K,Na,HbA1c,serum uric acid,Lipid
3)Adverse
Events:hyperuricemia,Hyponatremia,Edema
4)responder rate
1)Comparison of hypotensive effect by the level of sodium intake before drug administration
2)Comparison of responder rate by the level of sodium intake before drug administration
3)Change in urine albumin(before and after the treatment)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Medicine |
ARB/Diuretics combination
(Co-DIO combination tablets)
ARB/CCB
(DIOVAN 80 mg/amlodipine 5mg once a day or EXFORGE Combination tablets)
20 | years-old | <= |
Not applicable |
Male and Female
1)Hypertensive patients, who have been previously treated with monotherapy of an ARB for more than 4 weeks, however, whose blood pressure has not been reached the target defined by the JSH2009 criteria.
2)Patients who fully understand the study procedures explained to them using explanatory notes and have given written informed consent to participate in the study
1)The age <20 years
2)Patients with secondary hypertension
3)-7)Contraindication of Valsartan and Hydrochlorothiazide
8)Patients who are considered not eligible for the study by the attending doctor due to medical reasons
100
1st name | |
Middle name | |
Last name | Teruo Inoue |
Dokkyo Medical University
Department of Cardiovascular Medicine
880 kitakobayashi, Mibu, Tochigi, Japan
0282-86-1111
1st name | |
Middle name | |
Last name | Teruo Inoue |
Dokkyo Medical University
Department of Cardiovascular Medicine
880 kitakobayashi, Mibu, Tochigi, Japan
0282-86-1111
Department of Cardiovascular Medicine
None
Self funding
NO
2011 | Year | 07 | Month | 04 | Day |
Unpublished
Open public recruiting
2010 | Year | 10 | Month | 12 | Day |
2011 | Year | 02 | Month | 01 | Day |
2013 | Year | 10 | Month | 31 | Day |
2011 | Year | 07 | Month | 04 | Day |
2012 | Year | 10 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006996
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |